新型冠状病毒

Beijing’s failure to import mRNA Covid jabs ‘mind-boggling’, says BeiGene

Chinese biotech’s research chief calls decision ‘unfortunate’ as zero-Covid policy strangles economy

One of China’s most prominent biotech companies said it was “mind-boggling” that Beijing has not allowed sales of Covid-19 vaccines using technology pioneered by Moderna and BioNTech/Pfizer.

BeiGene’s research chief told the Financial Times it was “unfortunate” that Chinese authorities had not approved messenger RNA shots, which provide longer lasting and higher levels of protection than vaccines made by homegrown rivals.

China is the only big economy that has maintained strict quarantine for international arrivals and lockdowns to curb outbreaks of the virus. The pandemic policies have stunted the country’s economic growth and disrupted global supply chains.

您已阅读16%(665字),剩余84%(3620字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×